Voyager Therapeutics paid its 4 named executives $6.8M in total in FY2025 (Dec). CEO Alfred Sandrock, M.D., Ph.D. was paid $2.5M of that.
Pay$100 in the stock at the end of FY21 → $145
Pay of each named executive
Alfred Sandrock, M.D., Ph.D.Chief Executive Officer, President, and Director
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) | ||||||
| FY2022 (Dec) |
4 years
Jacquelyn Fahey SandellFormer Chief Legal Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Robin SwartzChief Business Officer & Chief Operating Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
Toby Ferguson, M.D., Ph.D.Former Chief Medical Officer
| FY2025 (Dec) | ||||||
| FY2024 (Dec) | ||||||
| FY2023 (Dec) |
3 years
CEO pay against the pay peers
In FY2025 (Dec), the median CEO pay of the 5 peers with pay on file was $3.2M. The CEO of Voyager Therapeutics was paid $2.5M, 22% below the median.
- 1MeiraGTx Holdings
- 2Solid Biosciences
- 3Neurogene
- 4Voyager TherapeuticsThis company
- 5Editas Medicine
- 64D Molecular Therapeutics
- 7Adverum Biotechnologies, Inc.Not disclosed
- 8Entrada TherapeuticsNot disclosed
- 9Foghorn TherapeuticsNot disclosed
- 10Lexeo TherapeuticsNot disclosed
- 11Monte Rosa TherapeuticsNot disclosed
- 12PepGen, Inc.Not disclosed
- 13Prelude Therapeutics Inc.Not disclosed
- 14Prime MedicineNot disclosed
- 15Stoke TherapeuticsNot disclosed
- 16Tenaya Therapeutics, Inc.Not disclosed
- 17Verve Therapeutics, Inc.Not disclosed
- 18Vigil Neuroscience, Inc.Not disclosed
- 19Wave Life SciencesNot disclosed
'%20fill='%23fff'/%3e%3cpath%20id='fullLogo-2'%20d='M18.156,40.577.011,29.356l0-18.125L18.147,0'%20transform='translate(-0.004%20-0.001)'%20fill='%23fff'/%3e%3cpath%20id='fullLogo-3'%20d='M35.133,14.327H26.354l4.389-7.163L35.127,0l4.395,7.164,4.389,7.163Z'%20transform='translate(-16.985)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-4'%20d='M51.052,93.782l0-8.211,18.178-3.019Z'%20transform='translate(-32.9%20-53.206)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-5'%20d='M69.213,11.223l-9.4,3.1L51.035,0Z'%20transform='translate(-32.892%20-0.001)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-6'%20d='M.01,11.23l9.387,3.1L18.148,0Z'%20transform='translate(-0.006%20-0.001)'%20fill='%2300b3cd'/%3e%3cpath%20id='fullLogo-7'%20d='M75.741,34.672l9.4-3.1,0,18.125Z'%20transform='translate(-48.815%20-20.345)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-8'%20d='M9.406,34.672l-9.4-3.1,0,18.125Z'%20transform='translate(-0.004%20-20.345)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-9'%20d='M18.15,93.786l.016-8.209L0,82.56Z'%20transform='translate(0%20-53.21)'%20fill='%233fbcd2'/%3e%3cpath%20id='fullLogo-10'%20d='M59.826,40.3,51.047,58.34l18.178-3.019Z'%20transform='translate(-32.9%20-25.974)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-11'%20d='M9.393,40.3l8.773,18.041L0,55.321Z'%20transform='translate(0%20-25.971)'%20fill='%2351c0d4'/%3e%3cpath%20id='fullLogo-12'%20d='M35.174,40.3H26.418l4.367,9.019,4.4,9.027,4.373-9.027,4.389-9.02Z'%20transform='translate(-17.026%20-25.974)'%20fill='%238fd4e2'/%3e%3c/svg%3e)
Pay of each named executive comes from the Summary Compensation Table of each proxy statement. Realized pay adds the value of options used and stock that vested. CEO pay of each peer comes from its own Pay versus Performance table.